You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AURKA

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Tumor Metastasis, Triple Negative Breast Tumors Trial in Edmonton, Montreal (LY3295668)

Completed
Has Results
  • Neoplasms
  • +6 more
  • Edmonton, Alberta, Canada
  • +2 more
Jun 29, 2021

Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • LY3295668 Erbumine
  • +2 more
  • San Francisco, California
  • +21 more
Aug 17, 2022

Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia Trial in Columbus (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 4, 2022

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Lung Cancer Metastatic, EGFR Gene Mutation Trial in San Francisco (Osimertinib, Alisertib)

Recruiting
  • Lung Cancer Metastatic
  • EGFR Gene Mutation
  • San Francisco, California
    University of California, San Francisco
Aug 10, 2022

Small Cell Lung Cancer Trial in Worldwide (LY3295668 Erbumine)

Completed
  • Small Cell Lung Cancer
  • LY3295668 Erbumine
  • Fayetteville, Arkansas
  • +39 more
Jul 30, 2021

Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory

Active, not recruiting
Has Results
  • Acute Megakaryoblastic Leukemia
  • +2 more
  • Miami, Florida
  • +2 more
May 4, 2021

Metastatic Breast Cancer Trial in Belgium, United States (LY3295668 Erbumine, Endocrine therapy, Midazolam)

Completed
  • Metastatic Breast Cancer
  • LY3295668 Erbumine
  • +2 more
  • Duarte, California
  • +6 more
May 29, 2020

Neuroblastoma Trial in Canada, United States (MLN8237, Irinotecan, Temozolomide)

Completed
Has Results
  • Neuroblastoma
  • Los Angeles, California
  • +12 more
Jul 10, 2019

Malignant Digestive System Tumor Trial in United States (Alisertib, Fluorouracil, Laboratory Biomarker Analysis)

Completed
  • Malignant Digestive System Neoplasm
  • New Haven, Connecticut
  • +4 more
Oct 5, 2018

Breast Tumors Trial in Australia, Belgium (Denosumab)

Terminated
  • Breast Neoplasms
  • Victoria, Australia
  • +5 more
Nov 26, 2018

Estrogen Receptor Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Rochester (Alisertib,

Completed
  • Estrogen Receptor Positive
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 2, 2018

Recurrent Melanoma, Stage IIIc Melanoma, Stage IV Melanoma Trial in Nashville (other, procedure, genetic)

Terminated
Has Results
  • Recurrent Melanoma
  • +2 more
  • laboratory biomarker identification and analysis
  • +4 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Apr 21, 2016

Hormone Refractory Prostate Cancer Trial in Tianjin (Docetaxel & Prednisone, DP & Targeted drugs, cisplatin & Etoposide)

Unknown status
  • Hormone Refractory Prostate Cancer
  • Docetaxel & Prednisone
  • +3 more
  • Tianjin, Tianjin, China
    Department of Interventional Oncology, Tianjin Medical Universit
Aug 4, 2014